Sign In
Buy QGEN
$36.45
+0.760 (+2.13%)
At Close: Jun 03, 2026
Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery
08:00am, Thursday, 19'th Feb 2026
SEATTLE, Wash. & VENLO, the Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--Parse Biosciences, a QIAGEN company (NYSE: QGEN, Frankfurt Prime Standard: QIA), and the leading provider of scalable and ac
QGEN's Q4 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down
09:10am, Friday, 06'th Feb 2026
QIAGEN shares decline as Q4 earnings meet estimates and revenues beat, with margin contraction and cautious 2026 guidance in focus.
Investors Buy Large Volume of Call Options on Qiagen (NYSE:QGEN)
01:56am, Friday, 06'th Feb 2026
Qiagen N.V. (NYSE: QGEN - Get Free Report) was the recipient of unusually large options trading activity on Thursday. Stock investors purchased 40,639 call options on the company. This is an increase
Qiagen N.V. (QGEN) Q4 2025 Earnings Call Transcript
02:44pm, Thursday, 05'th Feb 2026
Qiagen N.V. (QGEN) Q4 2025 Earnings Call Transcript
Qiagen (QGEN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
08:31pm, Wednesday, 04'th Feb 2026
While the top- and bottom-line numbers for Qiagen (QGEN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare
Qiagen (QGEN) Meets Q4 Earnings Estimates
06:56pm, Wednesday, 04'th Feb 2026
Qiagen (QGEN) came out with quarterly earnings of $0.62 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.64 per share a year ago.
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars
04:05pm, Wednesday, 04'th Feb 2026
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the fourth quarter and full-year 2025. Net sales for Q4 2025
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026
04:05pm, Tuesday, 03'rd Feb 2026
GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the first public showcase of QIAsprint Connect at SLAS
Earnings Preview: Qiagen (QGEN) Q4 Earnings Expected to Decline
11:06am, Wednesday, 28'th Jan 2026
Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Qiagen (QGEN) Expected to Announce Earnings on Wednesday
03:28am, Wednesday, 28'th Jan 2026
Qiagen (NYSE: QGEN - Get Free Report) is anticipated to release its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect Qiagen to post earnings of $0.59 per share and r
Qiagen: Takeover Optionality With A High-Quality Consumables Platform
08:00am, Tuesday, 27'th Jan 2026
QGEN is a consumable molecular diagnostics and life-science tools platform. They offer QuantiFERON, QIAstat-Dx, QIAcuity dPCR, and QDI bioinformatics. Recently, there's renewed takeover speculation af
QIAGEN Appoints Mark Stevenson to Supervisory Board
04:05pm, Monday, 26'th Jan 2026
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Mark Stevenson has been appointed as an independent member of the Supervi
Qiagen Explores Possible Sale After New Buyer Talks: Report
08:11am, Wednesday, 21'st Jan 2026
German life sciences tools company Qiagen N.V. (NYSE: QGEN) is reportedly reviewing strategic options, including a potential sale, as renewed takeover interest emerges.
Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock?
07:05am, Wednesday, 21'st Jan 2026
Qiagen (QGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
Qiagen weighing strategic options amid fresh takeover interest, Bloomberg reports
12:19pm, Tuesday, 20'th Jan 2026
Qiagen is weighing strategic options, including a potential sale of the diagnostics firm amid fresh takeover interest, Bloomberg News reported on Tuesday, citing people with knowledge of the matter.
